Evolution of Protective Immunization Against COVID-19 Among Hospital Workers in Health Care Facilities
-
- STATUS
- Recruiting
-
- End date
- Dec 15, 2022
-
- participants needed
- 1000
-
- sponsor
- Assistance Publique Hopitaux De Marseille
Summary
To measure the immunization rate (seroneutralization) in a population of exposed hospital workers (nursing staff assigned to dedicated COVID-19 care units, laboratory staff handling COVID-19 samples).
Description
Current studies on seroconversion and the time course of immunity following exposure to SARS-CoV-2 do not document: i) Seroconversion in populations in repeated and frequent contact with patients; ii) The temporal dynamics of seroconversion at medium term. These two elements are however fundamental in the comprehension and management of this epidemic or of its potential resurgence in the following months and years.
Objective: To measure the immunization rate (seroneutralization) in a population of exposed hospital workers (nursing staff assigned to dedicated COVID-19 care units, laboratory staff handling COVID-19 samples).
Secondary objectives:
- Determine the kinetics of the protective response over 12 months (4 times).
- Compare immunization profiles according to: gender, age, lockdown, blood type, occupational class, exposure, asymptomatic/symptomatic.
- Compare immunization kinetics between exposed and low-exposure hospital workers.
- To determine the characteristics of the ELISA test in comparison with the reference test (seroneutralization).
Perspectives
- To provide a reliable, affordable and faster serological test.
- Understanding of the natural evolution of seroprotection in a population over time.
- Sensitization to plasma donation for seropositive patients.
Details
| Condition | COVID19 |
|---|---|
| Treatment | Blood sample |
| Clinical Study Identifier | NCT05011344 |
| Sponsor | Assistance Publique Hopitaux De Marseille |
| Last Modified on | 29 August 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer